Prevalence of Psychiatric and Addictive Disorders in Patients with Psoriasis: A Cross-Sectional Study DOI Creative Commons
D Brănişteanu,

Roxana Paraschiva Ciobanu,

Daniel Brănișteanu

и другие.

Diagnostics, Год журнала: 2025, Номер 15(10), С. 1231 - 1231

Опубликована: Май 14, 2025

Background/Objectives: Psoriasis is a chronic inflammatory skin disease increasingly linked to psychiatric and behavioral comorbidities, including depression, anxiety, substance use disorders. Shared pathways, elevated IL-6, TNF-α, IL-17, may link psoriasis with disorders such as depression anxiety. The bidirectional interaction between systemic inflammation mental health exacerbate the burden affect treatment outcomes. objective of this study was determine prevalence comorbidities in patients explore potential demographic clinical correlations. Assessing these correlations contributes better understanding status patients, potentially influencing both therapeutic efficacy quality life. Methods: We conducted cross-sectional observational on 316 clinically histopathologically confirmed psoriasis, evaluated January 2021 March 2025 at Clinical Railway Hospital Iași, Romania. Psychiatric were assessed through interviews, medical record reviews, standardized tools AUDIT-C, Fagerström Test for Nicotine Dependence, Binge Eating Scale. severity using Area Severity Index (PASI). Results: Of participants, 88 (27.8%) had psychiatric/behavioral comorbidities. most frequent conditions tobacco disorder (11.1% overall; 39.8% among comorbid patients), alcohol (9.2%; 32.9%), binge eating (7.9%; 28.4%), anxiety (6.3%; 22.7%), (4.1%; 14.8%). Additional diagnoses included personality disorders, dementia, PTSD, sleep Conclusions: particularly are relatively common psoriasis. These findings support need regular screening integrated care approaches management.

Язык: Английский

The impact of a skin management model based on a precision quantitative ointment dispenser on skin symptoms and quality of life in elderly psoriasis patients DOI Creative Commons

Jing Shen,

Wei Zhou, Hui Zhang

и другие.

Journal of Dermatological Treatment, Год журнала: 2025, Номер 36(1)

Опубликована: Март 30, 2025

Objective This study explores the effects of a skin management model based on precision quantitative ointment dispenser symptoms and quality life in elderly psoriasis patients.

Язык: Английский

Процитировано

0
Molecular Link Between Psoriasis and Depression—Update on Pathophysiology DOI Open Access
Agnieszka Hołdrowicz, Agnieszka Żebrowska

International Journal of Molecular Sciences, Год журнала: 2025, Номер 26(6), С. 2467 - 2467

Опубликована: Март 10, 2025

Psoriasis disease is a chronic, systemic condition. Various epidemiological studies have indicated connection between psoriasis and psychiatric diseases. It obvious that easily visible psoriatic skin lesions cause stigmatization of patients impact noticeably their life quality, increasing the risk anxiety depressive disorders. More more attention recently being paid to common pathogenesis depression. The underlying chronic inflammation, depression also increasingly recognized as result neuroinflammation. Therefore, complexity processes both entities implies need observe in terms possible comorbidities, such mental disorders, regardless severity social stigmatization. This study aims present an update on pathophysiology

Язык: Английский

Процитировано

0
Prevalence of Psychiatric and Addictive Disorders in Patients with Psoriasis: A Cross-Sectional Study DOI Creative Commons
D Brănişteanu,

Roxana Paraschiva Ciobanu,

Daniel Brănișteanu

и другие.

Diagnostics, Год журнала: 2025, Номер 15(10), С. 1231 - 1231

Опубликована: Май 14, 2025

Background/Objectives: Psoriasis is a chronic inflammatory skin disease increasingly linked to psychiatric and behavioral comorbidities, including depression, anxiety, substance use disorders. Shared pathways, elevated IL-6, TNF-α, IL-17, may link psoriasis with disorders such as depression anxiety. The bidirectional interaction between systemic inflammation mental health exacerbate the burden affect treatment outcomes. objective of this study was determine prevalence comorbidities in patients explore potential demographic clinical correlations. Assessing these correlations contributes better understanding status patients, potentially influencing both therapeutic efficacy quality life. Methods: We conducted cross-sectional observational on 316 clinically histopathologically confirmed psoriasis, evaluated January 2021 March 2025 at Clinical Railway Hospital Iași, Romania. Psychiatric were assessed through interviews, medical record reviews, standardized tools AUDIT-C, Fagerström Test for Nicotine Dependence, Binge Eating Scale. severity using Area Severity Index (PASI). Results: Of participants, 88 (27.8%) had psychiatric/behavioral comorbidities. most frequent conditions tobacco disorder (11.1% overall; 39.8% among comorbid patients), alcohol (9.2%; 32.9%), binge eating (7.9%; 28.4%), anxiety (6.3%; 22.7%), (4.1%; 14.8%). Additional diagnoses included personality disorders, dementia, PTSD, sleep Conclusions: particularly are relatively common psoriasis. These findings support need regular screening integrated care approaches management.

Язык: Английский

Процитировано

0